Big Move For Galmed Pharmaceuticals Ltd.
Fri, Jun 04, 2021 at 05:33 PM
Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) soared at $3.4, representing a gain of 24.1%. On Thu, Jun 03, 2021, GLMD:NASDAQ hit a New 2-Week High of $2.74. The stock got featured on our News Catalysts scanner on Thu, May 13, 2021 at 10:34 AM in the 'INVESTOR UPDATE' category. From Thu, May 20, 2021, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Thu, Feb 11, 2021 at $6.25 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ)
Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
Top 10 Gainers:
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 41.95%
- Daxor Corporation (DXR:NYSEMKT), 37.55%
- American Superconductor Corporation (AMSC:NASDAQ), 37.46%
- Fuel Tech, Inc. (FTEK:NASDAQ), 36.28%
- SemiLEDs Corporation (LEDS:NASDAQ), 35.76%
- BBIG (BBIG:NASDAQ), 26.13%
- Resonant Inc. (RESN:NASDAQ), 25.62%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 24.09%
- JZXN (JZXN:NASDAQ), 22.77%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 22.37%